New York, NY – [March 2026] – Spark Biomedical has announced an investment by Northwell Holdings, the strategic corporate capital and innovation arm of Northwell Health, New York’s largest health system, set to be used for the growth of OhmBody™, Spark’s dedicated women’s wellness division which was launched with an initial focus on menstrual wellness.

“Northwell Health’s investment represents a powerful validation of the work we’re doing at Spark Biomedical,” says Daniel Powell, Chief Executive Officer, Spark Biomedical. “This partnership will accelerate the commercialization of OhmBody™ and advance additional initiatives built on our Neural Tourniquet™ technology. Together, we’re bringing forward innovative, non-invasive neuromodulation solutions that have the potential to transform patient care on a national scale.”

OhmBody™ offers a novel non-hormonal approach to menstrual wellness, utilizing Transcutaneous Auricular Neurostimulation® (tAN) via a wearable earpiece targeting branches of the vagus and trigeminal nerves. Of the 167 million menstruating women and adolescents in the U.S., heavy menstrual bleeding (HMB) affects an estimated 16 million, and can lead to anemia, impaired quality of life, and reduced occupational, educational or activity participation. OhmBody™ provides a safe, accessible, drug and hormone-free alternative to traditional approaches, as demonstrated in a recent clinical study published in Frontiers in Medicine.

“We are deeply committed to our collaboration with Spark and encouraged by the device’s capabilities to support menstrual health and the premenstrual syndrome use case, and we remain strongly optimistic about the meaningful benefits OhmBody™ can deliver for women’s health,” says Stacey E. Rosen, MD, FAHA, Executive Director of the Katz Institute for Women’s Health, Senior Vice President of Women’s Health at Northwell Health and Partners Council Professor of Women’s at the Zucker School of Medicine. “As part of our collaboration, Northwell Health participated in the company’s first‑in‑human clinical trial of the Neural Tourniquet, helping to establish a foundation for continued investigation and future advances in women’s health.”

About Spark Biomedical

Spark Biomedical, Inc. is a leading U.S.-based medical device developer, committed to unlocking the potential of bioelectronic medicine and bringing to market novel wearable neurostimulation treatment options in behavioral health, women’s health, and hemostasis.

Spark leverages its neuroscience and engineering expertise to empower healthcare providers and researchers with innovative, evidence-based tools designed to address complex care situations which exceed the capabilities of existing treatment options. Spark has received funding from federal institutions, such as the NIH and DoD, and continues to partner with private and academic institutions. Spark Biomedical is empowering a better way forward for the future of patient care and medical technology.

For media inquiries, please contact:
OhmBody PR Team
‍PR@ohmbody.com

About Northwell Holdings

Northwell Holdings (“Holdings”), a fully owned, for-profit subsidiary of Northwell Health, creates value for the health system by investing in early-stage companies, establishing commercial joint ventures, cultivating internally-developed ideas and bringing them to market, and advancing data collaborations that drive innovation in patient care, health diagnostics, and deep technology. We invest in companies that are aligned with Northwell’s mission, promote better health outcomes, improve patient experience, and increase efficiencies in care delivery and services. Through strategic collaborations, Holdings leverages the health system’s robust enterprise data assets to develop AI-enabled solutions that address healthcare inequities. We combine Northwell Health’s clinical and healthcare business expertise and entrepreneurial spirit to bring concepts to life. Northwell Health is New York's largest healthcare system. To learn more, visit us here and follow us on LinkedIn.

For media inquiries, please contact:
Sandy Dell
‍sdell@northwell.edu